跳至主要内容
临床试验/NCT00952562
NCT00952562已完成不适用

The Influence of Vitamin D on Mineral Metabolism, Blood Pressure and Pulse Wave Analysis in Healthy Individuals. A Randomised Double Blinded Placebo Controlled Trial.

Zealand University Hospital2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2009年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
2
主要终点
urinary calcium excretion

研究概览

简要总结

A randomized placebo controlled trial evaluating the effect of the recently recommended high doses of cholecalciferol (3000 IU/day) on mineral metabolism, blood pressure and pulse wave analysis in healthy individuals.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • > 18 years old
  • p 25OH vitaminD<50nmol/l
  • signed informed consent

排除标准

  • receiving antihypertensive or antidiabetic treatment
  • sarcoidoses
  • history of kidney stones
  • receiving 1-alfa-hydroxylated vitamin D treatment
  • plasma creatinin > 120 micromol/l
  • ionised calcium > 1,5 mmol/l
  • treatment with calcimimetics
  • active malignancy
  • intestinal malabsorption
  • active pancreatitis
  • former hospitalisation due to alcoholic related disease
  • using euphoriant drugs
  • pregnancy or risk of being pregnant or lactating women
  • Known allergy to cholecalciferol capsules

结局指标

主要结局

urinary calcium excretion

时间窗: before and after 16 weeks of intervention

次要结局

  • 25 hydroxyvitamin D(before and after 16 weeks og treatment)
  • 1,25 dihydroxyvitamin D(before and after 16 weeks of treatment)
  • urinary creatinin(before and after 16 weeks of treatment)
  • urinary protein(before and after 16 weeks of treatment)
  • urinary phosphorous(before and after 16 weeks of treatment)
  • p-FGF23(before and after 16 weeks of treatment)
  • blood pressure(before and after 16 weeks of treatment)
  • pulse wave velocity(before and after 16 weeks of treatment)
  • augmentation index(before and after 16 weeks of treatment)
  • central blood pressure(before and after 16 weeks of treatment)
  • p-phosphate(before and after 16 weeks of treatment)
  • ionised p-calcium(before and after 16 weeks of treatment)
  • p-iPTH(before and after 16 weeks of treatment)
  • alkalic phosphatase(before and after 16 weeks of treatment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验